A hip replacement lawsuit is an individual injury claim over a failed implant, often grouped with similar cases for pretrial work. The alternatives are a mass settlement program, state enforcement that does not pay patients, an FDA safety report, or medical care without legal action. At the center are metal-on-metal hips, where ball-and-cup wear sheds tiny metal particles. The FDA says that debris can damage bone and tissue, causing pain, loosening, device failure, and revision surgery to remove the device.
Official resources:
- Read the original report from FDA — Use this primary source to review the complete report.
- Explore the official data from FDA — Use this primary source to review the underlying data.
Table of Contents
- What does filing a lawsuit mean?
- How did mass settlements work?
- What paths do not involve suing?
- What medical options may come before revision?
- Who was left out of past payouts?
What does filing a lawsuit mean?
A lawsuit keeps your case separate even when many patients sue over the same device. For federal cases, multidistrict litigation transfers similar civil cases to one judge for coordinated pretrial work, according to the U.S.
District Court for the District of Kansas, to avoid duplicate discovery and inconsistent rulings (coordinated pretrial guide). That path fits patients with revision surgery, ongoing pain, tissue damage, or implant loosening. It requires medical proof linking the device to harm, plus records of implant model, revision, and costs.
How did mass settlements work?
Mass settlements paid groups of revision patients under shared rules and deadlines. Panish Shea Ravipudi LLP reported that DePuy and Johnson & Johnson announced a roughly $2.5 billion deal in 2013 covering about 8,000 U.S.
ASR patients who had revision surgery (settlement report). Stryker followed a similar route after its 2012 Rejuvenate and ABG II recall, agreeing to pay over $1.4 billion for revision-surgery claims. These programs traded speed and certainty for strict cutoffs, not open-ended eligibility.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
What paths do not involve suing?
State action is one alternative. Forty-six attorneys general reached a $120 million consent judgment with Johnson & Johnson and DePuy over promotion of ASR XL and Pinnacle Ultamet hips, with future claims tied to scientific data.
A patient can also file a voluntary FDA MedWatch safety report online, by phone, or by Form 3500, according to the FDA device safety program (safety reporting information). That creates a regulatory record but pays no compensation.
What medical options may come before revision?
For hip osteoarthritis, presurgical care can delay or avoid replacement. Healio reporting on the AAOS guideline lists corticosteroid injections, physical therapy, and non-narcotic pain drugs such as acetaminophen, NSAIDs or tramadol (guideline summary).
The same guideline recommends against hyaluronic acid for hip arthritis. Ask an orthopedist whether pain control, therapy, injection timing, and implant monitoring fit your joint damage and activity needs.
Who was left out of past payouts?
Major settlement programs required qualifying revision surgery before cutoff dates. Implanted patients without revision, or with later failure, were excluded and left to individual suit, monitoring, or medical care. Useful comparison before deciding:.
- Lawsuit: separate claim, needs proof, may take longer
- Mass settlement: faster if you meet revision and deadline rules
- Safety report: simple record, no payment
- Medical care: treats pain and function, preserves options
You Might Also Like
- Novo Nordisk Lawsuit vs Alternatives: Legal Paths Compared
- Camp Lejeune Settlement Offers vs Alternatives: Legal Paths Compared
- What Is New With Medical Device Lawsuits Mass Tort Litigation in September 2026? Latest court filings and agency notices and Key Takeaways